+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07111195

Evaluating ONCOhabitats Software to Support Surgery and Treatment Planning in Adults with IDH-Wildtype Glioblastoma

Led by Juan M Garcia-Gomez · Updated on 2025-08-08

140

Participants Needed

5

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating ONCOhabitats, an advanced MRI-based software, to support the clinical management of adults with IDH-wildtype glioblastoma, a type of high-grade brain tumor. This observational study aims to determine if imaging biomarkers from pre-surgical MRI scans can predict overall survival and help guide treatment decisions, including responses to temozolomide chemotherapy and immunotherapy. The study focuses on identifying vascular and molecular features within tumor-infiltrated brain regions that relate to patient prognosis. Participants will undergo preoperative MRI scans processed by ONCOhabitats, which segments the tumor into four biological habitats HAT, LAT, IPE, and VPE. During surgical tumor removal, tissue samples will be collected from these habitats when feasible. Researchers will analyze imaging biomarkers such as relative cerebral blood volume and correlate these with molecular markers like MGMT promoter methylation and gene expression profiles related to immunosuppression. Throughout the study, clinical and survival outcomes will be monitored for up to 24 months after surgery. Participants will provide informed consent and undergo complete preoperative MRI protocols. Researchers will assess the association between imaging and molecular data with patient prognosis, aiming to improve personalized treatment planning and better characterize glioblastoma biology.

CONDITIONS

Brief Title

Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)

Research Team

J

Juan Miguel García Gómez, PhD, Full Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here